Thursday 31 January 2019

MS drug Aubagio is now available in India


Aubagio Teriflunomide is a patented drug for treating relapsing form of Multiple Sclerosis and now it is available in India.

Teriflunomide is the generic name of Aubagio. It is now available as Teru MS 14mg and Terigen Teriflunamide 14 mg tablets.

To read more information on the generic drug of Aubagio use the below links.


Teriflunomide affects the immune system and reduces swelling and inflammation in the nervous system. Teriflunomide is used to reduce flare-ups in people with relapsing Multiple Sclerosis (MS) 



Sunday 27 January 2019

Teriflunomide to treat Relapsing forms of Multiple Sclerosis

Teriflunomide is a prescription medication in the form of tablet used to treat relapsing forms of multiple sclerosis (MS) in adults. Teriflunomide belongs to a class of drugs called immunomodulatory drugs.

The exact way how it works is still not known, but involves in a reducing in the number of certain immune cells. Teriflunomide comes in tablet form in two strength 14 mg and 7 mg. The most desired dosage is 14 mg and taken once a day.


Teriflunomide tablet can be taken with or without food.

Common side effects of Teriflunomide tablets may include hair thinning, diarrhea, flu, nausea and a burning or prickling feeling on the skin.

It is seen that these side effects does not matter after some time. For hair thinning a small dose of Biotin 5 mg can be taken.

Alternatives for Aubagio Teriflunomide


Generic Teriflunomide to treat relapsing forms of multiple sclerosis

The generic form of Aubagio Teriflunomide is now available from multiple pharmaceutical companies.

Alternatives for Aubagio Teriflunomide shown below:

Brand Name
Manufactured by
Terigen Teriflunomide 14 mg
Nuvigen Life Sciences Private Limited
Teru MS 14 mg / 7 mg
MSN Laboratories

Saturday 26 January 2019

Multiple Sclerosis a growing health concern


Multiple sclerosis is a disease where the immune system goes awry, our system thinks that the brain and spinal cord shouldn’t be there and tries to attack it. It is believed that there’s about a half a million people in the United States and may be over two million in the world.

Friday 25 January 2019

What causes Multiple Sclerosis?

Just like other autoimmune diseases, the exact cause of multiple sclerosis is unknown, but is linked to genetic and environmental factors. Genetic risk factors include being a woman and having genes that encode a specific type of immune molecule.

Environmental risk factors might include infections as well as vitamin D deficiency, which is an interesting one because it might help explain why the rates of multiple sclerosis are higher at the northern and southern poles compared to the equator where there's a lot more sunlight. Together these genetic and environmental influences might lead to the body not killing off immune cells that target myelin.

What is Multiple Sclerosis?

Multiple sclerosis is a demyelinating disease of the central nervous system, which includes the brain and the spinal cord.

In other words, it is a idiopathic auto immune disorder and it primarily affects the white matter of brain. It is one disease almost exclusively of the central nervous system.

Myelin is the protective sheath that surrounds the axons of neurons, allowing them to quickly send electrical impulses. This myelin is produced by oligodendrocytes, which are a group of cells that support neurons.

In multiple sclerosis, demyelination happens when the immune system inappropriately attacks and destroys the myelin, which makes communication between neurons break down, ultimately leading to all sorts of sensory, motor and cognitive problems.

Now the brain including the neurons in the brain is protected by things in the blood by the blood brain barrier (BBB), which only lets certain molecules and cells through from the blood. For immune cells like T and B cells that means having the right ligand or surface molecule to get through the blood brain barrier. Once a T cell makes its way in it can get activated by something it encounters - in the case of multiple sclerosis, it is activated by myelin.

Once the T-cell gets activated, it changes the blood brain barrier cells to express more receptors, and this allows immune cells to more easily bind and get in, multiple sclerosis is a type IV hypersensitivity reaction, or cell-mediated hypersensitivity. And this means that those myelin specific T-cells release cytokines like IL-1, IL-6, TNF-alpha, and intereferon-gamma, and together dilate the blood vessels which allow more immune cells to get in, as well as directly cause damage to the oligodendrocytes. They cytokines also attract B-cells and macrophages as part of the inflammatory reaction. Those B-cells begin to make antibodies that mark the myelin sheath proteins, and then the macrophages use those antibody markers to engulf and destroy the oligodendrocytes. Without oligodendrocytes, there's no myelin to cover the neurons, and this leaves behind areas of scar tissue, also called plaques or sclera. In multiple sclerosis, these immune attacks typically happen in bouts. In other words, an autoimmune attack on the oligodendrocytes might happen, and then regulatory T cells will come in to inhibit or calm down the other immune cells, leading to a reduction in the inflammation. Early on in multiple sclerosis, the oligodendrocytes will heal and extend out new myelin to cover the neurons, which is a process called remyelination.

Unfortunately, though, over time as the oligodendrocytes die off the remyelination stops and the damage becomes irreversible with the loss of axons. 

Teriflunomide shows long term benefits in patients with Multiple Sclerosis

Mark Freedman, MD, FAAN of Ottawa Hospital has done some lengthy investigations on using Teriflunomide for the treatment of relapsing forms of Multiple Sclerosis. It has shown to reduce relapses slowing disability and reducing MRI activity.

It has been found that patients on 13 years trial period did good and shown very less relapse with no significant change in disability.

Teriflunomide is taken as a single dose of 14mg or as two times in a day as 7mg. 

The most desired dosage is of taking once a day 14mg with or without food. Preferably in the morning.

Tuesday 8 January 2019

Teriflunomide Terigen 14mg

Teriflunomide is now manufactured in india as Teriflunomide Terigen 14mg. It can be taken once daily instead of Aubagio (teriflunomide)

Teriflunomide Terigen is manufactured by Nuvigen Life Sciences.

Teriflunomide Terigen is generic tablet for Aubagio (teriflunomide)